Stock Earnings

Question 1

Structure Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Structure Therapeutics Incの総資産は$903で、純lossは$-122です。

Question 2

GPCRの主要な財務比率は何ですか？

Accepted Answer

Structure Therapeutics Incの流動比率は23.76、純利益率は0、1株当たり売上高は$0です。

Question 3

Structure Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Currently Structure Therapeutics Inc data is not available.

Question 4

Structure Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Structure Therapeutics Incの純lossは$-122です。

Question 5

Structure Therapeutics Incに負債はありますか？

Accepted Answer

yes、Structure Therapeutics Incの負債は38です。

Question 6

Structure Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Structure Therapeutics Incの総発行済株式数は171.86株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	57	49	32	16	8	3
Research & Development	190	108	70	36	29	12
Operating Expenses	247	158	102	52	37	15
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-210	-122	-89	-51	-37	-15
Income Tax Expense	0	0	0	0	0	0
Net Income	-210	-122	-89	-52	-43	-16
Net Income Growth	91%	37%	71%	21%	169%	--
Shares Outstanding (Diluted)	175.46	157.92	110.19	109.76	109.76	109.76
Shares Change (YoY)	2%	43%	0%	0%	0%	--
EPS (Diluted)	-1.21	-0.77	-0.81	-0.48	-0.39	-0.14
EPS Growth	90%	-5%	69%	21%	173%	--
Free Cash Flow	-196	-117	-81	-46	-33	-14
Free Cash Flow Per Share	-1.11	-0.74	-0.73	-0.41	-0.3	-0.12
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-246	-158	-102	-52	-37	-15
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	1	0	0	0	0	0
EBIT	-247	-158	-102	-52	-37	-15
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Structure Therapeutics Inc (GPCR) Price